Search results for " economy"
Article
Process Economic Simulation for Scalable Production of Adenovirus
This application note discloses the process economic modelling of a modern start-to-finish adenovirus production process. The novel process was compared with a reference process in both stainless-st…
Article
Establishment of New Modern Plasma Fractionation Facilities in Asia
This week, the Process Development Forum talks to Dr. Neil Goss, an international consultant in biotechnology and plasma fractionation, past director of Research and Development at CSL BioPlasma, Aust…
Article
CDMOs Driving Emerging Bio/Pharma Success
…faster routes to new drug approval
• A robust equity investment environment across the economy
• Aggressive partnering, in-licensing, and acquisition by global bio/pharmaceutical compan…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
This week, the Process Development Forum talks with Günter Jagschies, Strategic Customer Relations Leader, Cytiva, about the biopharmaceutical market in Asia.
The Asian market is most often s…
Article
Taking Prepacked Columns to Manufacturing Scale
Prepacked chromatography columns in biomanufacturing can save time, but also present concerns related to delivery lead times, capacity, and operational cost.
Learn more here about ways to address…
Article
Evaluation of Performance of a Disposable mAb Affinity Chromatography Column Used Over Multiple Process Cycles
However, reuse of such columns could positively impact process economy. This application note demonstrates cycling of ReadyToProcess™ MabSelect SuRe™ LX columns in multiple process runs. Analysis of m…
Article
Development and Future of Protein A Chromatography Technology: Q&A with Jonathan Royce, Business Leader Chromatography Resins, Cytiva
That said, every generation of Protein A resin results in a lower cost of ownership and improved process economy for monoclonal antibody manufacturers. We believe that customers will find that MabSele…
Poster
A Next Generation Protein A Chromatography Resin for Improved Productivity and Bioburden Control
…ing new possibilities in cleaning and sanitization efficiency to address bioburden risks and process economy. The binding capacity has been increased more than 40% compared to its predecessor MabSele…
Article
Hybrid Bioprocessing: A Q&A with Andrew Sinclair
Process Development Forum speaks about hybrid bioprocessing with Andrew Sinclair, President and Founder of BioPharm Services
How would you define hybrid bioprocessing?
Hybrid processing is n…
Article
From Darwin to Recombinant Fc Multimers
IgG market will continue to dominate with 46% of market, followed by albumin, 18%, John Perkins stressed the importance of other plasma proteins to have a good process economy.
Some of the …